Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Dose Optimization in Elderly CML Patients Treated with Bosutinib after Intolerance or Failure of First-Line Tyrosine Kinase Inhibitors

Blood (2019) 134 (Supplement_1): 496.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals